Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

For Which Infections is Ceftazidime-Avibactam Approved?

FEB 13, 2017 | CONTAGION EDITORIAL STAFF


Madeline King, PharmD, assistant professor of Clinical Pharmacy at the University of the Sciences, Philadelphia College of Pharmacy in Philadelphia, Pennsylvania, explains for which infections ceftazidime-avibactam is approved by the US Food and Drug Administration.
 
Interview Transcript (slightly modified for readability)
 
“[Ceftazidime-avibactam] is currently only FDA-approved for intra-abdominal infections and urinary tract infections; however, it seems like a lot of people are using it for a lot of other infections, more severe infections [like] bacteremias [and] pneumonias. I’ve seen posters at these infectious disease conferences [that imply that] people are using it in other infections, and I’ve personally used [ceftazidime-avibactam] in other infections.
 
So [this combination is] only approved for two infections in the US, but in Europe it’s actually approved for pneumonia, as of, I believe, summer [2016].”
 
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


Advocacy and Research Foundation Partners
FEATURED
Big advances in treatment can